19:33:17 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-07 Kvartalsrapport 2024-Q3
2024-08-15 Kvartalsrapport 2024-Q2
2024-05-08 Ordinarie utdelning QLIFE 0.00 SEK
2024-05-07 Årsstämma 2024
2024-05-07 Kvartalsrapport 2024-Q1
2024-02-08 Bokslutskommuniké 2023
2024-01-16 Extra Bolagsstämma 2023
2023-11-13 Kvartalsrapport 2023-Q3
2023-08-17 Kvartalsrapport 2023-Q2
2023-05-26 Kvartalsrapport 2023-Q1
2023-05-05 Ordinarie utdelning QLIFE 0.00 SEK
2023-05-04 Årsstämma 2023
2023-03-24 Extra Bolagsstämma 2022
2023-02-16 Bokslutskommuniké 2022
2022-11-25 Kvartalsrapport 2022-Q3
2022-08-29 Kvartalsrapport 2022-Q2
2022-05-06 Ordinarie utdelning QLIFE 0.00 SEK
2022-05-05 Kvartalsrapport 2022-Q1
2022-05-05 Årsstämma 2022
2022-02-17 Bokslutskommuniké 2021
2021-11-08 Kvartalsrapport 2021-Q3
2021-08-16 Kvartalsrapport 2021-Q2
2021-05-06 Ordinarie utdelning QLIFE 0.00 SEK
2021-05-05 Årsstämma 2021
2021-05-05 Kvartalsrapport 2021-Q1
2021-02-18 Bokslutskommuniké 2020
2020-11-19 Extra Bolagsstämma 2020
2020-11-18 Kvartalsrapport 2020-Q3
2020-08-18 Kvartalsrapport 2020-Q2
2020-05-22 Ordinarie utdelning QLIFE 0.00 SEK
2020-05-20 Årsstämma 2020
2020-05-20 Kvartalsrapport 2020-Q1

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
Qlife Holding är verksamt inom medicinteknik. Bolaget är specialiserat inom forskning och utveckling av IVD-enheter. Enheterna används som biomarkörstester i blod och används som komplement till övriga tester inom vården. Samarbete utförs även med övriga aktörer på marknaden. Störst verksamhet återfinns inom den nordiska marknaden, med huvudkontoret i Helsingborg.
2023-12-01 08:00:00

Qlife Holding AB is pleased to announce the appointment of Peter Thorsen as the new Chief Financial Officer (CFO) of the company, effective January 1st, 2024. Mr. Thorsen will succeed Kasper Boel Rousøe, bringing with him a wealth of financial expertise and leadership experience.

Peter Thorsen is a Certified Public Accountant (CPA) with an impressive background in finance, having previously served in key roles at prominent organizations such as EY, DSV A/S, Domea, Widex A/S, and TeliaSonera. His extensive experience in finance leadership positions, combined with his strategic vision and analytical skills, make him a valuable addition to the Qlife team.

"We are delighted to welcome Peter Thorsen as our new CFO," says Thomas Warthoe, Chief Executive Officer of Qlife. "His proven track record and deep understanding of financial management will play a crucial role in supporting Qlife's growth and strategic initiatives. We are confident that Peter's expertise will contribute significantly to our future success."

Peter Thorsen expressed his enthusiasm for joining Qlife Holding AB, stating, "I am honored to be part of a company that is at the forefront of innovation in the healthcare industry. Qlife's commitment to advancing digital health solutions aligns with my own professional values, and I am eager to contribute to the company's financial success."

As the incoming CFO, Peter Thorsen will oversee the financial strategy, planning, and reporting functions at Qlife Holding AB. His appointment reflects the company's commitment to maintaining strong financial governance and fostering sustainable growth.